{
    "doi": "https://doi.org/10.1182/blood.V104.11.2302.2302",
    "article_title": "Allogeneic Stem-Cell Transplantation for Patients with De Novo Acute Myeloid Leukemia Not in Complete Response: Results of a Survey from the European Group for Blood and Bone Marrow Transplantation (EBMT). ",
    "article_date": "November 16, 2004",
    "session_type": "Poster Sessions",
    "abstract_text": "Allogeneic stem-cell transplantation (alloSCT) is the most powerful antileukemic post-remission strategy in patients with acute myeloid leukemia (AML), and has shown its capability of increase leukemia-free survival and survival in earlier phases of the disease. However, the possible role of alloSCT in AML patients not in CR is mostly unknown, and deserves specific investigation. For this purpose, a survey within the EBMT registry including patients who underwent an undepleted alloSCT from an HLA-identical sibling for advanced AML (not in CR) was performed. We have analyzed 977 adults patients with AML submitted to alloSCT for a primary refractory disease (REF, n=346), first relapse (REL1, n=506) or second relapse (REL2, n=125) from 1990 to 2002 in EBMT centers. Median age was 40 (16 \u2013 73) and 55% of patients were male. FAB classification was: M1/M2, 44%; M4/M5, 33%; M6, 5%; M0, 4%; M3, 3%; M7, 3%. Median time from diagnosis to alloSCT was 136, 219 and 403 days for REF, REL1, and REL2 subgroups, respectively. Bone marrow was the source of stem cells in a higher proportion of patients with relapsed disease as compared to refractory AML (59% for REL1 + REL2 vs 41% for REF, p<0001). Conditioning regimen included TBI in 56% of cases. No significant differences among subgroups (REF/REL1/REL2) were observed in terms of donor-recipient\u2019s CMV status and TBI usage. After a median follow-up of 22 months, the main estimates of the outcome at 2 years are depicted in the following table:  Group . Refractory . 1st relapse . 2nd relapse . * All the results are expressed in % \u00b1SE Relapse incidence 57 \u00b16 51 \u00b14 54 \u00b18 Transplant-related mortality 25 \u00b15 26 \u00b14 31 \u00b16 Overall survival 25 \u00b13 26 \u00b12 24 \u00b12 Leukemia-free survival 18 \u00b12 23 \u00b12 16 \u00b13 Group . Refractory . 1st relapse . 2nd relapse . * All the results are expressed in % \u00b1SE Relapse incidence 57 \u00b16 51 \u00b14 54 \u00b18 Transplant-related mortality 25 \u00b15 26 \u00b14 31 \u00b16 Overall survival 25 \u00b13 26 \u00b12 24 \u00b12 Leukemia-free survival 18 \u00b12 23 \u00b12 16 \u00b13 View Large In conclusion, although the overall outcome of HLA-identical sibling allotransplant for patients with non-CR AML is poor, a small fraction of patients, of approximately 20%, seems to benefit from the procedure in this otherwise incurable disease. A further analysis is addressed to the recognition of favorable prognostic factors in order to identify subgroups of patients with advanced AML who are candidates to allogeneic transplantation.",
    "topics": [
        "bone marrow transplantation",
        "complete remission",
        "leukemia, myelocytic, acute",
        "stem cells",
        "transplantation",
        "human leukocyte antigens",
        "leukemia",
        "disease remission",
        "follow-up",
        "prognostic factors"
    ],
    "author_names": [
        "Jordi Esteve",
        "Myriam Labopin",
        "Jurgen Finke",
        "Athanasios Fassas",
        "Catherine Cordonnier",
        "Axel Arthur Fauser",
        "Mauricette Michallet",
        "Francesco Frassoni",
        "Nicholas Harhalakis",
        "Jossy Reiffers",
        "E. Paolo Alessandrino",
        "Gerhard Ehninger",
        "Norbert C. Gorin",
        "Vanderson Rocha"
    ],
    "author_dict_list": [
        {
            "author_name": "Jordi Esteve",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Myriam Labopin",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jurgen Finke",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Athanasios Fassas",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Catherine Cordonnier",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Axel Arthur Fauser",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mauricette Michallet",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Francesco Frassoni",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Nicholas Harhalakis",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Jossy Reiffers",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "E. Paolo Alessandrino",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Gerhard Ehninger",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Norbert C. Gorin",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Vanderson Rocha",
            "author_affiliations": [
                "Hematology, Hospital Clinic, Barcelona, Spain; ",
                "Acute Leukaemia WP Registry, EBMT, France; ",
                "University of Freiburg, Germany; ",
                "The George Papanicolaou General Hospital, Thelassoniki, Greece; ",
                "Hopital Henri Mondor, Creteil, France; ",
                "Knochenmarktransplantation und Haematologie/Onkologie, Idar-Oberstein, Germany; ",
                "Hopital E. Herriot, Lyon, France; ",
                "Ospedale San Martino, Genova, Italy; ",
                "Evangelismos Hospital, Athens, Greece; ",
                "CHU Bordeaux, Hopital Haut-leveque, Pessac, France; ",
                "Policlinico San Matteo, Pavia, Italy; ",
                "Universitaetsklinikum Dresden, Germany; ",
                "Hopital Saint Antoine, Paris, France; ",
                "Hopital St Louis, Paris, France and ",
                "Acute Leukemia Working Party of the EBMT."
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-04-26T02:25:25",
    "is_scraped": "1"
}